Pharmaceutical Packaging Market - Global Outlook & Forecast 2022-2027

335 pages

92 tables

171 charts

5 region

18 countries

30 company

4 segments

Purchase Options

$4200.00
$4999.00
$5999.00
$2000.00

Have a question?

Please get in touch with our team in case of any queries

+1-312-235-2040

THE GLOBAL PHARMACEUTICAL PACKAGING MARKET SIZE WAS VALUED AT USD 81 BILLION IN 2021 AND IS EXPECTED TO REACH USD 106.37 BILLION BY 2027, GROWING AT A CAGR OF 4.65% DURING THE FORECAST PERIOD.

The Global Pharmaceutical Packaging Market Size, Share, And Growth Forecast By: 

  • Type: Primary (Blister Packs, Bottles, Vials, Ampoules, And Others), Secondary, and Tertiary
  • Material: Paper, Glass, Plastic, and Others
  • End-User: Pharmaceutical Companies, CMO/ CDMO, and Plastic
  • Geography:North America, Europe, APAC, Latin America, and the Middle East & Africa

Industry Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share, & Forecast 2022-2027

Customize this Report

This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize

PHARMACEUTICAL PACKAGING MARKET REPORT SCOPE

REPORT ATTRIBUTEDETAILS
Market Size (2027)USD 106.37 BILLION
Market Size (2021)USD 81 BILLION
CAGR (2021-2027)4.65%
Base Year2021
Forecast Year2022-2027
Market SegmentsType, Material, End-User, and Geography
Geographic AnalysisNorth America, Europe, APAC, Latin America, and Middle East & Africa
KEY VENDORSAmcor, Aptar Group, Berry Global, Gerresheimer, and WestRock
Interested in this Report?

Download a Sample!

The global pharmaceutical packaging market is expected to grow at a CAGR of 4.65% and will cross USD 106.37 billion by 2027 from USD 81 billion in 2021 from 2021-2027. The demand for advanced and innovative solutions, such as self-administered drug delivery devices, is rising in high-income countries, bringing lucrative opportunities for the pharmaceutical packaging market. In addition, diseases have increased in recent years, including various types of flu, the COVID-19 pandemic, monkeypox, and more. Rising healthcare expenses and growing consumer awareness regarding healthier lifestyles drive the industry.

The growing chronic disease prevalence, growth in the biologics market, and technological advancements are anticipated to propel the market. However, fluctuations in raw material prices, emerging markets such as newly developed drugs, and lack of compliance with regulatory standards hamper the market's growth.

Driving Factors In The Global Pharmaceutical Packaging Market

  • Rising pharmaceutical industry across the globe
  • A surge in demand for flexible packaging
  • Rising demand for biological products and emerging treatments such as cell and gene therapies
  • Aging Demographics of Industrialized Countries

Active Mergers And Acquisitions Playing A Key Role In Smooth Functioning For The Growth of The Global Pharmaceutical Packaging Market

  • In February 2018, Berry Global acquired Clopay Plastic Products Company for a purchase price of USD 475 million.
  • Berry Global completed the acquisition of RPC Group in July 2019. RPC Group is one of the global leaders in plastics conversion for packaging and non-packaging markets.
  • On June 11, 2019, Amcor acquired Bemis Company, a global manufacturer of flexible packaging products. Its flexible segment develops and supplies flexible packaging globally. In FY2021, the Flexible segment accounted for approximately 78% of Amcor’s net sales.
  • In November 2021, Gerresheimer acquired the IP of a new generation cartridge-based autoinjector suitable for small and large molecules, enhancing its broad portfolio, medical devices, and primary packaging from Midas Pharma. Midas Pharma is a Germany-based pharmaceutical company.
  • In 2018, Gerresheimer acquired Sensile Medical, a drug delivery technology company, and thus the company extended its business model in the OEM for drug delivery platforms for pharmaceutical and biopharmaceutical customers.

Increasing Virtual Consultations Is Anticipating The Growth Of Aluminium-Based Drug Packaging

High-income countries from North America and Europe are witnessing an increased adoption of virtual visits and e-prescriptions, leading to a large dependency on the home delivery of medicines. The home delivery of goods is one of the significant challenges for pharmaceutical packaging companies as the customers are not aware of the proper disposal of packaged products and materials, leading to a substantial environmental impact. Due to this concern, aluminum packaging is one of the improved solutions to overcome this issue.

INDUSTRY’S ONGOING TRENDS

Eco-Friendly Packaging
Around 85% of the waste produced by healthcare operations, including pharmaceutical and medical equipment packaging, is non-hazardous and, therefore, exhibits the potential to be replaced by other eco-friendly and reusable alternatives, enabling significant cost savings. Many pharma companies are shifting to sustainable packaging that uses recyclable materials and biodegradable plastics. Sustainable pharmaceutical packaging is expected to grow during the forecast period. PET (polyethylene terephthalate) is a recyclable plastic material. It is a very versatile material for the manufacturing of pharmaceutical products packaging. It has a good carbon dioxide (CO2), oxygen, and moisture barrier, allowing it to store liquids and solids as fresh as possible. Europe is expected to lead the growth in the biodegradable pharmaceutical packaging market. In Europe, the key players in the global biodegradable pharmaceutical packaging market include Gerresheimer, Berry Global, International Paper, and Amcor.

Introduction Of Anti-Counterfeiting Features
A counterfeit pharmaceutical product is deliberately and fraudulently mislabelled concerning identity. Counterfeit pharmaceutical products may include products with correct ingredients, wrong ingredients, without active ingredients, wrong ingredients with the inaccurate quantity of an active ingredient, or with fake packaging. The global pharmaceutical packaging market has witnessed a major challenge with the growing incidences of counterfeit products. As a result, many manufacturers in recent years have introduced several anti-counterfeiting features to fight the distribution of counterfeit pharmaceutical products. These anti-counterfeiting features include using thermochromic inks for labeling, holograms, QR code, RFID labels, and many more. Some innovations include child-resistant, senior-friendly & high barrier, unit-dose, multi-dose, and specialty film packaging.

IMPACT OF COVID-19

COVID-19 has shown adverse effects on the global healthcare industry and has thus contributed to hindering the growth of the pharmaceutical packaging market. The COVID-19 impact on the pharmaceutical sector included changes in demand, regulation adjustments, R&D process changes, and supply chain restructuring. In addition, trends such as industry slow-down, delays in approvals, modifying clinical trial methods, self-sufficiency in the pharmaceutical product supply chain, and variations in consumption of health & nutritional products are expected to be some of the long-term impacts of the COVID-19 pandemic on the pharmaceutical industry globally.

During the pandemic, pharma packaging companies witnessed stable revenue growth in 2020. Major pharmaceutical packaging companies increased their production capacity to support the increased demand for pre-filled syringes, blister packs, ampoules/vials, bags, cartridges, containers, and bottles. This was mainly due to a surge in demand for COVID-19-related medications and vaccines. Moreover, pharmaceutical packaging for biologics, sterile packaging, smart packaging, patient focus packaging, cleanroom expansion, and others are anticipated to drive the global pharmaceutical packaging market in the long term.

SEGMENTATION ANALYSIS

INSIGHTS BY TYPE SEGMENTATION
Primary pharmaceutical packaging segmentation accounted for the largest market share of 70.20% in 2021, owing to the growing demand for blister packs, bottles, vials, ampoules, pouches, sachets, and bags. The blister packs account for a significant revenue share of 35.23% in 2021 in the global pharmaceutical packaging market due to the high demand for prescription and non-prescription medications/drugs, among which the demand for generic drugs is the highest among LMIC. Although the pharmaceutical sector accounts for the major share of the global market, a consistent surge in blister packaging demand contributes to its cost-effectiveness. The evolution from simple bulk packaging materials toward ready-to-sterilize (RTS) primary packaging components and systems is the dominant trend in the primary packaging segment of the market

Innovations in secondary pharmaceutical packaging include developing child-resistant (CR) cartons, tamper-evident (TE) cartons, and cold-chain packaging. The secondary packaging segment accounted for 20.30% of the global pharmaceutical packaging market share.

Tertiary packaging is used for the safe handling and smooth transportation of products. Examples of tertiary packaging include plastic bags, shrink wraps, and cardboard boxes. The increasing trend of e-pharmacy will likely further the adoption of tertiary packaging in the pharmaceutical packaging market. It is expected to grow with a CAGR of 3.96% during the forecast period.

INSIGHTS FROM MATERIAL SEGMENTATION
Paper materials accounted for the highest revenue share of 39.36% in 2021 in the global pharmaceutical packaging market due to their increasing demand in secondary and tertiary packaging, low cost, and increasing focus on recyclable and eco-friendly materials. Demand for paper-based packaging, both corrugated and folding cartons, has been rising across Europe during the last few years owing to its largest pharmaceutical market and the largest exporter of pharmaceuticals. WestRock Company is one of the leading manufacturers of paper-based packaging.

Plastics held the third largest share in 2021 in the pharmaceutical packaging market by material segmentation. It is expected to grow at the highest CAGR of 4.94% from 2022-2027, powered due its growing demand in all three packaging types. In addition, plastics are widely used in packaging because of their versatility, flexibility, and cost-effectiveness. However, due to its non-decomposable properties and its ban for use because of its environmental issues as it produces a high quantity of greenhouse gases has banned its use in several countries. As a result, recyclable plastics are in high demand. The most widely used-recyclable plastics in pharmaceutical packaging include PET, HDPE, and PP, among which PET is the most commonly recycled plastic worldwide, followed by HDPE. Several governments and companies are developing initiatives to use recycled plastics as packaging material for pharmaceutical medicines and supplies.

INSIGHTS FROM END-USER SEGMENTATION
Pharmaceutical companies account for the highest market share of 48.18% in the global pharmaceutical packaging market by end-user segment. It is expected to grow at the highest CAGR of 5.10% during the forecast period. The highest revenue share of pharma companies is because pharmaceutical companies are the primary source for the pharmaceutical packaging market. As the demand for pharmaceuticals continues to grow, the need for packaging has also increased significantly.

GEOGRAPHICAL ANALYSIS

North America accounts for 36% of the global pharmaceutical packaging market share. The growing pharmaceutical sales in North America are the major driving factor for the pharmaceutical packaging market in the region. North America, in particular the US, will continue to be the largest pharma packaging market long term due to the advanced drug-producing sector. The US market is expected to maintain moderate growth due to the increasing aging population, robust innovations, and increasing consumer demand for sophisticated packaging.

Emerging markets such as Brazil, China, and India are anticipated to grow at the fastest rate, which can be attributed to their large population and demographic factors such as a growing young population and longer life expectancy. APAC is estimated to show the highest growth of 5.01% during the forecast period. The pharmaceutical industry is booming, especially in developing countries such as China, India, and Brazil, as well as in developed countries such as the US, UK, and Germany. According to the India Brand Equity Foundation (IBEF), India is the largest provider of generic drugs globally. At the same time, the Indian pharmaceutical sector supplies around 50% of the global demand for several vaccines, 40% demand for generic drugs in the US, and 25% of all tablets in the UK.

VENDORS LANDSCAPE

The global pharmaceutical packaging market is highly dynamic and competitive, with several international, regional, and local vendors offering a diverse and comprehensive range of pharmaceutical packaging products with wide applications. The key players in the industry are Berry Global, Amcor, Gerresheimer, WestRock, and AptarGroup.The industry also has the presence of prominent players, some of which include ACG, Airnov, Borosil, CCL Industries, and Drug Plastics Group.

Vendors' Activities In The Pharmaceutical Packaging Market Include:

  • Expansion activities are helping the vendors to improve their global distribution networks, allowing the players to explore untapped opportunities.
  • Large-scale investments and funding in the pharmaceutical packaging market are seen through varied conglomerates and investment firms.

A Diverse Range of Pharmaceutical Packaging Products Offered In The Industry

  • A surge in technological innovations in pharmaceutical packaging and several new product launches can be witnessed in the pharmaceutical packaging market. For instance, on October 27, 2021, Amcor launched its dual-chamber pouch for drug-device combination product packaging in Europe.
  • Global players are projected to increase their footprint in the pharmaceutical packaging market, especially in terms of features and price.
  • Companies with a strong footprint in the developed nations are strategically expanding their business in low- and middle-income countries (LMIC), which can be attributed to the growing aging population and chronic diseases in those countries.

Frequently Asked Questions

How big is the pharmaceutical packaging market?

The global pharmaceutical packaging market size was valued at USD 81.00 billion in 2021 and is expected to surpass USD 106.37 billion by 2027. The growth can be attributable to the surge in demand for pharmaceutical packaging in emerging economies such as Brazil, India, and China. In addition, rising healthcare expenses and growing consumer awareness regarding healthier lifestyles drive the industry.

What is the growth rate of the global pharmaceutical packaging market?

The global pharmaceutical packaging market share is growing at a CAGR of 4.65% from 2021-2027.

Who are the key players in the global pharmaceutical packaging market?

Amcor, Aptar Group, Berry Global, Gerresheimer, and WestRock are the key players in the global pharmaceutical packaging market.

Which region will dominate the global pharmaceutical packaging market?

North America accounts for the highest pharmaceutical packaging market share, attributable to growing pharmaceutical demand, a growing aging population, robust innovations, and increasing consumer demand for sophisticated packaging.

What are the factors driving the pharmaceutical packaging market?

Growing demand for pharmaceuticals, increasing demand for primary pharmaceutical packaging, and rising demand for flexible packaging are the key factors driving the global pharmaceutical packaging market.

The global pharmaceutical packaging market is expected to grow at a CAGR of approximately 4.65% from 2021 to 2027.

The following factors are likely to contribute to the growth of the global pharmaceutical packaging market during the forecast period:

  • Growing Demand for Pharmaceuticals
  • Growing Demand for Primary Pharmaceutical Packaging
  • Rising Demand for Flexible Packaging

Base Year: 2021

Forecast Year: 2022-2027

The report considers the present scenario of the global pharmaceutical packaging market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.

Key Vendors

  • Amcor
    • Business Overview
    • Product Offerings
    • Key Strategies
    • Key Strengths
    • Key Opportunities
  • Aptar Group
  • Berry Global
  • Gerresheimer
  • WestRock

Other Prominent Vendors

  • ACG
    • Business Overview
    • Product Offerings
  • Airnov
  • AVI Global Plast
  • BD
  • Bilcare
  • Borosil
  • CCL Industries
  • Coesia
  • Drug Plastics Group
  • DWK Life Sciences
  • LOG
  • Meghmani Group
  • Neelam Global
  • Nolato
  • Nemera
  • PolyCine
  • RENOLIT
  • Schur Flexibles Holding
  • Specialty Polyfilms
  • SGD Pharma
  • SCHOTT
  • Sippex IV bags
  • SUPER OLEFINS
  • West Pharmaceutical Services
  • Wihuri Group

Segmentation by Type

  • Primary
    • Blister Packs
    • Bottles
    • Vials
    • Ampoules
    • Others
  • Secondary
  • Tertiary

Segmentation by Material

  • Paper
  • Glass
  • Plastic
  • Others

Segmentation by End-User

  • Pharmaceutical Companies
  • CMO/ CDMO
  • Plastic

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • Italy
    • Spain
    • France
    • UK
  • APAC
    • Japan
    • China
    • South Korea
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • South Africa

EXHIBIT 1 SEGMENTATION OF THE GLOBAL PHARMACEUTICAL PACKAGING MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021

EXHIBIT 3 IMPACT OF SURGE IN FOCUS ON ECO-FRIENDLY PACKAGING

EXHIBIT 4 GLOBAL PRODUCTION CAPACITIES OF BIOPLASTICS (1,000 TONNES)

EXHIBIT 5 IMPACT OF IMPLEMENTATION OF NANOTECHNOLOGY IN PHARMACEUTICAL PACKAGING

EXHIBIT 6 MARKET VALUE OF NANOTECHNOLOGY WORLDWIDE 2012–2020 ($ BILLION)

EXHIBIT 7 IMPACT OF ADVANCES IN PACKAGING MATERIALS

EXHIBIT 8 IMPACT OF RISE IN DEMAND FOR PHARMACEUTICALS

EXHIBIT 9 RANKING OF INDUSTRIAL SECTORS BY OVERALL SECTOR R&D INTENSITY (R&D AS PERCENTAGE OF NET SALES) 2019

EXHIBIT 10 AGGREGATE VALUE OF GLOBAL PHARMACEUTICAL INDUSTRY 2003–2021 ($ TRILLIONS)

EXHIBIT 11 IMPACT OF HIGH DEMAND FOR PRIMARY PHARMACEUTICAL PACKAGING

EXHIBIT 12 MARKET SHARE OF GLOBAL CELL AND GENE THERAPY DRUG DELIVERY DEVICES 2019

EXHIBIT 13 TYPES OF PRIMARY PHARMACEUTICAL PACKAGING

EXHIBIT 14 INJECTABLES PACKAGING BY STANDALONE OR INTEGRATED STATUS 2019

EXHIBIT 15 IMPACT OF SURGE IN DEMAND FOR FLEXIBLE PACKAGING

EXHIBIT 16 ADVANTAGES OF FLEXIBLE PACKAGING

EXHIBIT 17 SHARE OF FLEXIBLE PACKAGING BY APPLICATION IN US (EXCLUDING FOOD) 2021

EXHIBIT 18 REVENUE OF AMCOR COMPANY IN RIGID AND FLEXIBLE PACKAGING 2019–2021 ($ MILLION)

EXHIBIT 19 SALES OF MAJOR FLEXIBLE AND RIGID PACKAGING PRODUCTS OF AMCOR 2021 ($ MILLION)

EXHIBIT 20 IMPACT OF SURGE IN HOME DELIVERY FOR PHARMACEUTICAL PRODUCTS

EXHIBIT 21 IMPACT OF STRINGENT REGULATORY STANDARDS

EXHIBIT 22 IMPACT OF VOLATILITY IN RAW MATERIAL PRICES

EXHIBIT 23 GLOBAL PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 1 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021 & 2027 (%)

EXHIBIT 2 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021 & 2027 (%)

EXHIBIT 3 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY END USER 2021 & 2027 (%)

EXHIBIT 4 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY GEOGRAPHY 2021 & 2027 (%)

EXHIBIT 5 FIVE FORCES ANALYSIS 2021

EXHIBIT 6 INCREMENTAL GROWTH BY TYPE 2021 & 2027

EXHIBIT 7 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY PRODUCT

EXHIBIT 8 PHARMACEUTICAL PACKAGING MARKET BY TYPE: MARKET OVERVIEW

EXHIBIT 9 PHARMACEUTICAL PACKAGING MARKET BY TYPE: GROWTH IMPACT

EXHIBIT 10 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY TYPE: INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 11 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY TYPE: ABSOLUTE GROWTH (%)

EXHIBIT 12 GLOBAL PRIMARY PHARMACEUTICAL PACKAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 13 GLOBAL PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 14 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY BLISTER PACKS 2021–2027 ($ BILLION)

EXHIBIT 15 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY BOTTLES 2021–2027 ($ BILLION)

EXHIBIT 16 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY VIALS 2021–2027 ($ BILLION)

EXHIBIT 17 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY AMPOULES 2021–2027 ($ BILLION)

EXHIBIT 18 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY OTHERS 2021–2027 ($ BILLION)

EXHIBIT 19 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 20 GLOBAL SECONDARY PHARMACEUTICAL PACKAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 21 GLOBAL SECONDARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 22 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 23 GLOBAL TERTIARY PHARMACEUTICAL PACKAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 24 GLOBAL TERTIARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 25 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 26 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027

EXHIBIT 27 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY MATERIAL

EXHIBIT 28 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY MATERIAL: MARKET OVERVIEW

EXHIBIT 29 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY MATERIAL: GROWTH IMPACT

EXHIBIT 30 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY MATERIAL: INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 31 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY MATERIAL: ABSOLUTE GROWTH (%)

EXHIBIT 32 GLOBAL CONSUMPTION BY PAPER CATEGORY 2018 ( TONNES) (%)

EXHIBIT 33 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY PAPER: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 34 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY PAPER 2021–2027 ($ BILLION)

EXHIBIT 35 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 36 GLASS PROS AND CONS IN PARENTERAL PACKAGING

EXHIBIT 37 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY GLASS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 38 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY GLASS 2021–2027 ($ BILLION)

EXHIBIT 39 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 40 DIFFERENCE BETWEEN THERMOPLASTICS AND THERMOSETS

EXHIBIT 41 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY PLASTIC: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 42 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY PLASTIC 2021–2027 ($ BILLION)

EXHIBIT 43 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 44 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY OTHER MATERIALS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 45 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY OTHER MATERIALS 2021–2027 ($ BILLION)

EXHIBIT 46 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 47 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 48 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY END USER

EXHIBIT 49 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY END USER: MARKET OVERVIEW

EXHIBIT 50 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY END USER: GROWTH IMPACT

EXHIBIT 51 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY END USER: INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 52 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY END USER: ABSOLUTE GROWTH (%)

EXHIBIT 53 LEADING COUNTRIES IN GENERICS MARKET 2019

EXHIBIT 54 TOP 20 BRANDED PHARMACEUTICAL PLAYERS RANKED BY ENTERPRISE VALUE ($ BILLION) 2021

EXHIBIT 55 PATENT EXPIRIES & GENERICS OPPORTUNITIES 2020–2026

EXHIBIT 56 PATENTS EXPIRED BETWEEN 2020 AND 2026

EXHIBIT 57 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY PHARMACEUTICAL COMPANIES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 58 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY PHARMACEUTICAL COMPANIES 2021–2027 ($ BILLION)

EXHIBIT 59 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 60 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY CMOS/CDMOS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 61 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY CMOS/CDMOS 2021–2027 ($ BILLION)

EXHIBIT 62 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 63 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY OTHER END USERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 64 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY OTHER END USERS 2021–2027 ($ BILLION)

EXHIBIT 65 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 66 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 67 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY GEOGRAPHY

EXHIBIT 68 GLOBAL PHARMACEUTICALS MARKET 2003–2020 ($ TRILLIONS)

EXHIBIT 69 GEOGRAPHICAL BREAKDOWN (BY MAIN MARKETS) OF SALES OF NEW MEDICINES LAUNCHED BETWEEN 2015 & 2020 (%)

EXHIBIT 70 ANNUAL GROWTH RATE FOR PHARMACEUTICAL R&D EXPENDITURE 2006–2020 (%)

EXHIBIT 71 GLOBAL PLASTIC PRODUCTION 2016–2020 (MT)

EXHIBIT 72 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ BILLION)

EXHIBIT 73 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY GEOGRAPHY: ABSOLUTE GROWTH (%)

EXHIBIT 74 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 75 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET: KEY COUNTRIES 2021 ($ BILLION)

EXHIBIT 76 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 77 INCREMENTAL GROWTH BY TYPE 2021 & 2027

EXHIBIT 78 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027

EXHIBIT 79 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 80 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027

EXHIBIT 81 PHARMACEUTICAL SALES IN US 2017–2021 ($ BILLION)

EXHIBIT 82 US PHARMACEUTICAL R&D EXPENDITURE & ANNUAL GROWTH RATE (%) 2017–2020

EXHIBIT 83 US PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 84 SALES OF PATENTED AND NON-PATENTED DRUGS IN CANADA 2011–2019 ($ BILLIONS)

EXHIBIT 85 HEALTH EXPENDITURE IN CANADA 2011–2019 ($ BILLIONS)

EXHIBIT 86 CANADA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 87 EUROPEAN PHARMACEUTICAL MANUFACTURING VALUE 2019 ($ MILLION)

EXHIBIT 88 PLASTIC PRODUCTION IN EUROPE 2016–2020 (MT)

EXHIBIT 89 TOP FIVE COUNTRIES IN PACKAGING PAPER PRODUCTION 2015–2019

EXHIBIT 90 CONVERTER PLASTICS DEMAND BY COUNTRIES (MT) 2020

EXHIBIT 91 CONVERTERS PLASTICS DEMAND BY TYPES (MT) 2020

EXHIBIT 92 EUROPE PHARMACEUTICAL PACKAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 93 EUROPE PHARMACEUTICAL PACKAGING MARKET: KEY COUNTRIES 2021 ($ BILLION)

EXHIBIT 94 EUROPE PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 95 INCREMENTAL GROWTH BY TYPE 2021 & 2027

EXHIBIT 96 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027

EXHIBIT 97 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 98 INCREMENTAL GROWTH IN EUROPE 2021 & 2027

EXHIBIT 99 DRUG SALES IN GERMAN PHARMACEUTICAL  MARKET 2019 (IN $ BILLION AND MILLION PACKAGING UNITS)

EXHIBIT 100 PHARMACEUTICAL PRODUCTION IN GERMANY 2015–2018 ($ BILLION)

EXHIBIT 101 GERMANY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 102 UK PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 103 REVENUE OF OTC PHARMACEUTICALS SALES 2017–2021 ($ MILLION)

EXHIBIT 104 PHARMACEUTICAL PACKAGING MARKET IN FRANCE 2021–2027 ($ BILLION)

EXHIBIT 105 BIOSIMILAR CONSUMPTION IN ITALY 2018

EXHIBIT 106 PHARMACEUTICAL INDUSTRY IN ITALY BY NATIONALITY OF OWNERSHIP (% OF TOTAL)

EXHIBIT 107 EXPORT SALES OF PHARMACEUTICAL ITALIAN-OWNED COMPANIES (% OF OVERALL TURNOVER)

EXHIBIT 108 ITALY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 109 OTC PHARMACEUTICALS IN SPAIN: TOTAL REVENUE 2017–2021

EXHIBIT 110 GENERATION OF PLASTIC PACKAGING WASTE IN SPAIN, 2017-2020 (IN 1,000 MT)

EXHIBIT 111 GENERATION OF PLASTIC PACKAGING WASTE IN SPAIN 2017–2020 ( 1,000 MT)

EXHIBIT 112 PHARMACEUTICAL PACKAGING MARKET IN SPAIN 2021–2027 ($ BILLION)

EXHIBIT 113 PHARMACEUTICAL SPENDING BY COUNTRY 2018 ($ BILLION)

EXHIBIT 114 APAC PHARMACEUTICAL PACKAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 115 APAC PHARMACEUTICAL PACKAGING MARKET: KEY COUNTRIES 2021 ($ BILLION)

EXHIBIT 116 PHARMACEUTICAL PACKAGING MARKET IN APAC 2021–2027 ($ BILLION)

EXHIBIT 117 INCREMENTAL GROWTH BY TYPE 2021 & 2027

EXHIBIT 118 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027

EXHIBIT 119 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 120 INCREMENTAL GROWTH IN APAC 2021 & 2027

EXHIBIT 121 REVENUE SEGMENTATION OF CHINESE PHARMACEUTICAL INDUSTRY 2018 ($ BILLION)

EXHIBIT 122 CHINA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 123 TOTAL PHARMACEUTICALS MARKET ($ THOUSANDS), 2017 - 2020

EXHIBIT 124 PHARMACEUTICAL PACKAGING MARKET IN JAPAN 2021–2027 ($ BILLION)

EXHIBIT 125 DRUG EXPENDITURE DYNAMICS 1995-2020

EXHIBIT 126 SOUTH KOREA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 127 BIOSIMILARS APPROVED BY COUNTRY/REGION, 2019

EXHIBIT 128 INTERNATIONAL TRADE (EXPORT) IN PHARMACEUTICALS ($ BILLION)

EXHIBIT 129 INDIA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 130 AUSTRALIA PLASTIC RECYCLING TARGET 2021

EXHIBIT 131 AUSTRALIA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 132 LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 133 LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET: KEY COUNTRIES 2021 ($ BILLION)

EXHIBIT 134 LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 135 INCREMENTAL GROWTH BY TYPE 2021 & 2027

EXHIBIT 136 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027

EXHIBIT 137 INCREMENTAL GROWTH BY END USER 2021 & 2027

EXHIBIT 138 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027

EXHIBIT 139 PACKAGING PRODUCTION BY MATERIAL IN BRAZIL 2020 (%)

EXHIBIT 140 MAIN PLASTIC RESINS CONSUMED IN BRAZILIAN MARKET 2020 (%)

EXHIBIT 141 BRAZIL PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 142 MEXICO PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 143 PHARMACEUTICAL INDUSTRY SALES 2017–2021 ($ BILLION)

EXHIBIT 144 PHARMACEUTICAL EXPORTS AND IMPORTS 2017–2021 ($ BILLION)

EXHIBIT 145 OTC SALES 2017–2020 (%)

EXHIBIT 146 ARGENTINA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 147 MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 148 MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET: KEY COUNTRIES 2021 ($ BILLION)

EXHIBIT 149 MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 150 INCREMENTAL GROWTH BY TYPE 2021 & 2027

EXHIBIT 151 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027

EXHIBIT 152 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 153 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027

EXHIBIT 154 PERCENTAGE SHARE OF BIOSIMILARS BY THERAPEUTIC AREAS 2020 (%)

EXHIBIT 155 TURKEY PHARMACEUTICALS MARKET COMPOSITION 2019 ($ BILLION)

EXHIBIT 156 TURKEY PHARMACEUTICALS MARKET COMPOSITION 2019 ($ BILLION)

EXHIBIT 157 TURKEY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 158 SAUDI ARABIA PHARMACEUTICALS MARKET COMPOSITION 2019 ($ BILLION)

EXHIBIT 159 SAUDI ARABIA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 160 SOUTH AFRICA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

EXHIBIT 161 GLOBAL PHARMACEUTICAL PACKAGING: DIVERSIFIED & PURE PLAYERS

EXHIBIT 162 KEY VENDORS IN PHARMACEUTICAL PACKAGING: MARKET DOMINANCE ANALYSIS

EXHIBIT 163 KEY VENDORS IN PHARMACEUTICAL PACKAGING: CAPABILITIES & EXPERTISE ASSESSMENTS

EXHIBIT 164 AMCOR: TOTAL REVENUE 2019–2021 ($ MILLION)

EXHIBIT 165 AMCOR: GLOBAL SALES BREAKDOWN 2021 (%)

EXHIBIT 166 AMCOR: R&D EXPENDITURE 2019–2021 ($ MILLION)

EXHIBIT 167 APTARGROUP: TOTAL REVENUE 2019–2021 ($ BILLION)

EXHIBIT 168 APTARGROUP: REVENUE BY PHARMACEUTICAL SEGMENT 2019–2021 ($ BILLION)

EXHIBIT 169 BERRY GLOBAL: TOTAL REVENUE 2019–2021 ($ MILLION)

EXHIBIT 170 GERRESHEIMER: TOTAL REVENUE 2019–2021 ($ MILLION)

EXHIBIT 171 WESTROCK: TOTAL REVENUE 2019–2021 ($ MILLION)

 

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2015–2021

TABLE 3 ENVIRONMENT IMPACT OF PACKAGING MATERIALS

TABLE 4 PERCENTAGE SHARE OF VARIOUS BIOPHARMACEUTICALS BETWEEN 2015 AND 2020

TABLE 5 PERCENTAGE SHARE OF VARIOUS BIOPHARMACEUTICALS BETWEEN 2015 AND 2020

TABLE 6 PHARMACEUTICAL PRODUCT RECALLS DUE TO LABELING ERRORS

TABLE 7 ADVANTAGES AND DISADVANTAGES OF RUBBERS

TABLE 8 TOP 5 PAPERBOARD AND PACKAGING PAPER PRODUCTION COUNTRIES 2015–2019 (MT)

TABLE 9 TOP 5 PAPER & PAPERBOARD PRODUCING COUNTRIES 2019 (MILLION MT)

TABLE 10 TOP 3 PAPER & PAPERBOARD CONSUMING APAC COUNTRIES 2019 (MT)

TABLE 11 MEXICO PHARMACEUTICAL MARKET 2018–2020 ($ BILLION)

TABLE 12 MEXICO PLASTIC RESINS PRODUCTION AND MARKET SIZEV2017 – 2020 ($ BILLION)

TABLE 13 AMCOR: MAJOR PRODUCT OFFERINGS

TABLE 14 APTARGROUP: MAJOR PRODUCT OFFERINGS

TABLE 15 BERRY GLOBAL: MAJOR PRODUCT OFFERINGS

TABLE 16 GERRESHEIMER: MAJOR PRODUCT OFFERINGS

TABLE 17 WESTROCK: MAJOR PRODUCT OFFERINGS

TABLE 18 ACG: MAJOR PRODUCT OFFERINGS

TABLE 19 AIRNOV: MAJOR PRODUCT OFFERINGS

TABLE 20 AVI GLOBAL PLAST: MAJOR PRODUCT OFFERINGS

TABLE 21 BD: MAJOR PRODUCT OFFERINGS

TABLE 22 BILCARE: MAJOR PRODUCT OFFERINGS

TABLE 23 BOROSIL: MAJOR PRODUCT OFFERINGS

TABLE 24 CCL INDUSTRIES: MAJOR PRODUCT OFFERINGS

TABLE 25 COESIA: MAJOR PRODUCT OFFERINGS

TABLE 26 DRUG PLASTICS GROUP: MAJOR PRODUCT OFFERINGS

TABLE 27 DWK LIFE SCIENCES: MAJOR PRODUCT OFFERINGS

TABLE 28 LOG: MAJOR PRODUCT OFFERINGS

TABLE 29 MEGHMANI GROUP: MAJOR PRODUCT OFFERINGS

TABLE 30 NEELAM GLOBAL: MAJOR PRODUCT OFFERINGS

TABLE 31 NOLATO: MAJOR PRODUCT OFFERINGS

TABLE 32 NEMERA: MAJOR PRODUCT OFFERINGS

TABLE 33 POLYCINE: MAJOR PRODUCT OFFERINGS

TABLE 34 RENOLIT: MAJOR PRODUCT OFFERINGS

TABLE 35 SCHUR FLEXIBLES HOLDING: MAJOR PRODUCT OFFERINGS

TABLE 36 SPECIALTY POLYFILMS: MAJOR PRODUCT OFFERINGS

TABLE 37 SGD PHARMA: MAJOR PRODUCT OFFERINGS

TABLE 38 SCHOTT: MAJOR PRODUCT OFFERINGS

TABLE 39 SIPPEX IV BAGS: MAJOR PRODUCT OFFERINGS

TABLE 40 SUPER OLEFINS: MAJOR PRODUCT OFFERINGS

TABLE 41 WEST PHARMACEUTICAL SERVICES: MAJOR PRODUCT OFFERINGS

TABLE 42 WIHURI GROUP: MAJOR PRODUCT OFFERINGS

TABLE 43 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)

TABLE 44 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 45 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 ($ BILLION)

TABLE 46 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 (%)

TABLE 47 GLOBAL PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

TABLE 48 GLOBAL PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 (%)

TABLE 49 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 ($ BILLION)

TABLE 50 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 (%)

TABLE 51 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 52 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 (%)

TABLE 53 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 ($ BILLION)

TABLE 54 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 (%)

TABLE 55 NORTH AMERICA PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

TABLE 56 NORTH AMERICA PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 (%)

TABLE 57 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 ($ BILLION)

TABLE 58 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 (%)

TABLE 59 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 60 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 (%)

TABLE 61 EUROPE PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 ($ BILLION)

TABLE 62 EUROPE PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 (%)

TABLE 63 EUROPE PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

TABLE 64 EUROPE PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 (%)

TABLE 65 EUROPE PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 ($ BILLION)

TABLE 66 EUROPE PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 (%)

TABLE 67 EUROPE PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 68 EUROPE PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 (%)

TABLE 69 APAC PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 ($ BILLION)

TABLE 70 APAC PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 (%)

TABLE 71 APAC PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

TABLE 72 APAC PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 (%)

TABLE 73 APAC PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 ($ BILLION)

TABLE 74 APAC PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 (%)

TABLE 75 APAC PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 76 APAC PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 (%)

TABLE 77 LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 ($ BILLION)

TABLE 78 LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 (%)

TABLE 79 LATIN AMERICA PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

TABLE 80 LATIN AMERICA PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 (%)

TABLE 81 LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 ($ BILLION)

TABLE 82 LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 (%)

TABLE 83 LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 84 LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 (%)

TABLE 85 MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 ($ BILLION)

TABLE 86 MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 (%)

TABLE 87 MIDDLE EAST & AFRICA PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)

TABLE 88 MIDDLE EAST & AFRICA PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 (%)

TABLE 89 MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 ($ BILLION)

TABLE 90 MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 (%)

TABLE 91 MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 ($ BILLION)

TABLE 92 MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 (%)

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

 

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY TYPE

4.3.2 MARKET SEGMENTATION BY MATERIAL

4.3.3 MARKET SEGMENTATION BY END USER

4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

 

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

 

6 MARKET AT A GLANCE

7 INTRODUCTION

7.1 OVERVIEW

 

8 PREMIUM INSIGHTS

8.1 MARKET SCENARIO

 

9 MARKET OPPORTUNITIES & TRENDS

9.1 INCREASE IN FOCUS ON ECO-FRIENDLY PACKAGING

9.2 IMPLEMENTATION OF NANOTECHNOLOGY IN PHARMACEUTICAL PACKAGING

9.3 ADVANCES IN PACKAGING MATERIALS

 

10 MARKET GROWTH ENABLERS

10.1 RISE IN DEMAND FOR PHARMACEUTICALS

10.2 HIGH DEMAND FOR PRIMARY PHARMACEUTICAL PACKAGING

10.3 SURGE IN DEMAND FOR FLEXIBLE PACKAGING

 

11 MARKET RESTRAINTS

11.1 SURGE IN HOME DELIVERY OF PHARMACEUTICAL PRODUCTS

11.2 STRINGENT REGULATORY STANDARDS

11.3 VOLATILITY IN RAW MATERIAL PRICES

 

12 MARKET LANDSCAPE

12.1 MARKET OVERVIEW

12.2 MARKET SIZE & FORECAST

12.2.1 INSIGHT BY TYPE

12.2.2 INSIGHT BY MATERIAL

12.2.3 INSIGHT BY END USER

12.2.4 INSIGHT BY GEOGRAPHY

12.3 FIVE FORCES ANALYSIS

12.3.1 THREAT OF NEW ENTRANTS

12.3.2 BARGAINING POWER OF SUPPLIERS

12.3.3 BARGAINING POWER OF BUYERS

12.3.4 THREAT OF SUBSTITUTES

12.3.5 COMPETITIVE RIVALRY

 

13 TYPE

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 PRIMARY

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 BLISTER PACKS

13.3.4 MARKET SIZE & FORECAST

13.3.5 BOTTLES

13.3.6 MARKET SIZE & FORECAST

13.3.7 VIALS

13.3.8 MARKET SIZE & FORECAST

13.3.9 AMPOULES

13.3.10 MARKET SIZE & FORECAST

13.3.11 OTHERS

13.3.12 MARKET SIZE & FORECAST

13.3.13 MARKET BY GEOGRAPHY

13.4 SECONDARY

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 MARKET BY GEOGRAPHY

13.5 TERTIARY

13.5.1 MARKET OVERVIEW

13.5.2 MARKET SIZE & FORECAST

13.5.3 MARKET BY GEOGRAPHY

 

14 MATERIAL

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 PAPER

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.3.3 MARKET BY GEOGRAPHY

14.4 GLASS

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.4.3 MARKET BY GEOGRAPHY

14.5 PLASTIC

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

14.5.3 MARKET BY GEOGRAPHY

14.6 OTHERS

14.6.1 MARKET OVERVIEW

14.6.2 MARKET SIZE & FORECAST

14.6.3 MARKET BY GEOGRAPHY

 

15 END USER

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 MARKET OVERVIEW

15.3 PHARMACEUTICAL COMPANIES

15.3.1 MARKET OVERVIEW

15.3.2 MARKET SIZE & FORECAST

15.3.3 MARKET BY GEOGRAPHY

15.4 CMOS/CDMOS

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

15.4.3 MARKET BY GEOGRAPHY

15.5 OTHERS

15.5.1 MARKET OVERVIEW

15.5.2 MARKET SIZE & FORECAST

15.5.3 MARKET BY GEOGRAPHY

 

16 GEOGRAPHY

16.1 MARKET SNAPSHOT & GROWTH ENGINE

16.2 GEOGRAPHIC OVERVIEW

 

17 NORTH AMERICA

17.1 MARKET OVERVIEW

17.2 MARKET SIZE & FORECAST

17.3 NORTH AMERICA: TYPE

17.4 NORTH AMERICA: MATERIAL

17.5 NORTH AMERICA: END USER

17.6 KEY COUNTRIES

17.6.1 US: MARKET SIZE & FORECAST

17.6.2 CANADA: MARKET SIZE & FORECAST

 

18 EUROPE

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.3 EUROPE: TYPE

18.4 EUROPE: MATERIAL

18.5 EUROPE: END USER

18.6 KEY COUNTRIES

18.6.1 GERMANY: MARKET SIZE & FORECAST

18.6.2 UK: MARKET SIZE & FORECAST

18.6.3 FRANCE: MARKET SIZE & FORECAST

18.6.4 ITALY: MARKET SIZE & FORECAST

18.6.5 SPAIN: MARKET SIZE & FORECAST

 

19 APAC

19.1 MARKET OVERVIEW

19.2 MARKET SIZE & FORECAST

19.3 APAC: TYPE

19.4 APAC: MATERIAL

19.5 APAC: END USER

19.6 KEY COUNTRIES

19.6.1 CHINA: MARKET SIZE & FORECAST

19.6.2 JAPAN: MARKET SIZE & FORECAST

19.6.3 SOUTH KOREA: MARKET SIZE & FORECAST

19.6.4 INDIA: MARKET SIZE & FORECAST

19.6.5 AUSTRALIA: MARKET SIZE & FORECAST

 

20 LATIN AMERICA

20.1 MARKET OVERVIEW

20.2 MARKET SIZE & FORECAST

20.3 LATIN AMERICA: TYPE

20.4 LATIN AMERICA: MATERIAL

20.5 LATIN AMERICA: END USER

20.6 KEY COUNTRIES

20.6.1 BRAZIL: MARKET SIZE & FORECAST

20.6.2 MEXICO: MARKET SIZE & FORECAST

20.6.3 ARGENTINA: MARKET SIZE & FORECAST

 

21 MIDDLE EAST & AFRICA

21.1 MARKET OVERVIEW

21.2 MARKET SIZE & FORECAST

21.3 MIDDLE EAST & AFRICA: TYPE

21.4 MIDDLE EAST & AFRICA: MATERIAL

21.5 MIDDLE EAST & AFRICA: END USER

21.6 KEY COUNTRIES

21.6.1 TURKEY: MARKET SIZE & FORECAST

21.6.2 SAUDI ARABIA: MARKET SIZE & FORECAST

21.6.3 SOUTH AFRICA: MARKET SIZE & FORECAST

 

22 COMPETITIVE LANDSCAPE

22.1 COMPETITION OVERVIEW

22.2 MARKET SHARE ANALYSIS

22.2.1 AMCOR

22.2.2 APTARGROUP

22.2.3 BERRY GLOBAL

22.2.4 GERRESHEIMER

22.2.5 WESTROCK

 

23 KEY COMPANY PROFILES

23.1 AMCOR

23.1.1 BUSINESS OVERVIEW

23.1.2 PRODUCT OFFERINGS

23.1.3 KEY STRATEGIES

23.1.4 KEY STRENGTHS

23.1.5 KEY OPPORTUNITIES

23.2 APTARGROUP

23.2.1 BUSINESS OVERVIEW

23.2.2 PRODUCT OFFERINGS

23.2.3 KEY STRATEGIES

23.2.4 KEY STRENGTHS

23.2.5 KEY OPPORTUNITIES

23.3 BERRY GLOBAL

23.3.1 BUSINESS OVERVIEW

23.3.2 PRODUCT OFFERINGS

23.3.3 KEY STRATEGIES

23.3.4 KEY STRENGTHS

23.3.5 KEY OPPORTUNITIES

23.4 GERRESHEIMER

23.4.1 BUSINESS OVERVIEW

23.4.2 PRODUCT OFFERINGS

23.4.3 KEY STRATEGIES

23.4.4 KEY STRENGTHS

23.4.5 KEY OPPORTUNITIES

23.5 WESTROCK

23.5.1 BUSINESS OVERVIEW

23.5.2 PRODUCT OFFERINGS

23.5.3 KEY STRATEGIES

23.5.4 KEY STRENGTHS

23.5.5 KEY OPPORTUNITIES

 

24 OTHER PROMINENT VENDORS

24.1 ACG

24.1.1 BUSINESS OVERVIEW

24.1.2 PRODUCT OFFERINGS

24.2 AIRNOV

24.2.1 BUSINESS OVERVIEW

24.2.2 PRODUCT OFFERINGS

24.3 AVI GLOBAL PLAST

24.3.1 BUSINESS OVERVIEW

24.3.2 PRODUCT OFFERINGS

24.4 BD

24.4.1 BUSINESS OVERVIEW

24.4.2 PRODUCT OFFERINGS

24.5 BILCARE

24.5.1 BUSINESS OVERVIEW

24.5.2 PRODUCT OFFERINGS

24.6 BOROSIL

24.6.1 BUSINESS OVERVIEW

24.6.2 PRODUCT OFFERINGS

24.7 CCL INDUSTRIES

24.7.1 BUSINESS OVERVIEW

24.7.2 PRODUCT OFFERINGS

24.8 COESIA

24.8.1 BUSINESS OVERVIEW

24.8.2 PRODUCT OFFERINGS

24.9 DRUG PLASTICS GROUP

24.9.1 BUSINESS OVERVIEW

24.9.2 PRODUCT OFFERINGS

24.10 DWK LIFE SCIENCES

24.10.1 BUSINESS OVERVIEW

24.10.2 PRODUCT OFFERINGS

24.11 LOG

24.11.1 BUSINESS OVERVIEW

24.11.2 PRODUCT OFFERINGS

24.12 MEGHMANI GROUP

24.12.1 BUSINESS OVERVIEW

24.12.2 PRODUCT OFFERINGS

24.13 NEELAM GLOBAL

24.13.1 BUSINESS OVERVIEW

24.13.2 PRODUCT OFFERINGS

24.14 NOLATO

24.14.1 BUSINESS OVERVIEW

24.14.2 PRODUCT OFFERINGS

24.15 NEMERA

24.15.1 BUSINESS OVERVIEW

24.15.2 PRODUCT OFFERINGS

24.16 POLYCINE

24.16.1 BUSINESS OVERVIEW

24.16.2 PRODUCT OFFERINGS

24.17 RENOLIT

24.17.1 BUSINESS OVERVIEW

24.17.2 PRODUCT OFFERINGS

24.18 SCHUR FLEXIBLES HOLDING

24.18.1 BUSINESS OVERVIEW

24.18.2 PRODUCT OFFERINGS

24.19 SPECIALTY POLYFILMS

24.19.1 BUSINESS OVERVIEW

24.19.2 PRODUCT OFFERINGS

24.20 SGD PHARMA

24.20.1 BUSINESS OVERVIEW

24.20.2 PRODUCT OFFERINGS

24.21 SCHOTT

24.21.1 BUSINESS OVERVIEW

24.21.2 PRODUCT OFFERINGS

24.22 SIPPEX IV BAGS

24.22.1 BUSINESS OVERVIEW

24.22.2 PRODUCT OFFERINGS

24.23 SUPER OLEFINS

24.23.1 BUSINESS OVERVIEW

24.23.2 PRODUCT OFFERINGS

24.24 WEST PHARMACEUTICAL SERVICES

24.24.1 BUSINESS OVERVIEW

24.24.2 PRODUCT OFFERINGS

24.25 WIHURI GROUP

24.25.1 BUSINESS OVERVIEW

24.25.2 PRODUCT OFFERINGS

 

25 REPORT SUMMARY

25.1 KEY TAKEAWAYS

25.2 STRATEGIC RECOMMENDATIONS

 

26 QUANTITATIVE SUMMARY

26.1 MARKET BY GEOGRAPHY

26.2 MARKET BY TYPE

26.3 MARKET BY TYPE (PRIMARY)

26.4 MARKET BY MATERIAL

26.5 MARKET BY END USER

26.6 NORTH AMERICA BY TYPE

26.7 NORTH AMERICA BY TYPE (PRIMARY)

26.8 NORTH AMERICA  BY MATERIAL

26.9 NORTH AMERICA BY END USER

26.10 EUROPE BY TYPE

26.11 EUROPE BY TYPE (PRIMARY)

26.12 EUROPE BY MATERIAL

26.13 EUROPE BY END USER

26.14 APAC BY TYPE

26.15 APAC BY TYPE ( PRIMARY)

26.16 APAC BY MATERIAL

26.17 APAC BY END USER

26.18 LATIN AMERICA BY TYPE

26.19 LATIN AMERICA BY TYPE (PRIMARY)

26.20 LATIN AMERICA BY MATERIAL

26.21 LATIN AMERICA BY END USER

26.22 MIDDLE EAST & AFRICA BY TYPE

26.23 MIDDLE EAST & AFRICA BY TYPE (PRIMARY)

26.24 MIDDLE EAST & AFRICA BY MATERIAL

26.25 MIDDLE EAST & AFRICA BY END USER

 

27 APPENDIX

27.1 ABBREVIATIONS

Select a license type that suits your business needs

Single User Licence

$4200.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email

5 User Licence

$4999.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Corporate Licence

$5999.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Datasheet Licence

$2000.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Frequently Asked Questions

How big is the pharmaceutical packaging market?

The global pharmaceutical packaging market size was valued at USD 81.00 billion in 2021 and is expected to surpass USD 106.37 billion by 2027. The growth can be attributable to the surge in demand for pharmaceutical packaging in emerging economies such as Brazil, India, and China. In addition, rising healthcare expenses and growing consumer awareness regarding healthier lifestyles drive the industry.

What is the growth rate of the global pharmaceutical packaging market?

The global pharmaceutical packaging market share is growing at a CAGR of 4.65% from 2021-2027.

Who are the key players in the global pharmaceutical packaging market?

Amcor, Aptar Group, Berry Global, Gerresheimer, and WestRock are the key players in the global pharmaceutical packaging market.

Which region will dominate the global pharmaceutical packaging market?

North America accounts for the highest pharmaceutical packaging market share, attributable to growing pharmaceutical demand, a growing aging population, robust innovations, and increasing consumer demand for sophisticated packaging.

What are the factors driving the pharmaceutical packaging market?

Growing demand for pharmaceuticals, increasing demand for primary pharmaceutical packaging, and rising demand for flexible packaging are the key factors driving the global pharmaceutical packaging market.